Nobivac Myxo-RHD Plus RSS Authorised This medicine is authorised for use in the European Union myxomatosis and rabbit haemorrhagic viral disease vaccine (live recombinant) Medicine Veterinary Authorised
Page contentsPage contents Overview Product information Product details Authorisation details Assessment history News on Nobivac Myxo-RHD Plus Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Nobivac Myxo-RHD Plus : EPAR - Medicine overviewReference Number: EMA/498857/2019 English (EN) (81.94 KB - PDF)First published: 16/12/2019 Last updated: 02/09/2025 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View español (ES) (81.97 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View čeština (CS) (93.99 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View dansk (DA) (83.34 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View Deutsch (DE) (82.76 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View eesti keel (ET) (82.18 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View ελληνικά (EL) (93.76 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View français (FR) (82.44 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View hrvatski (HR) (92.27 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View íslenska (IS) (83.29 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View Gaeilge (GA) (83.57 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View italiano (IT) (82.29 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View latviešu valoda (LV) (94.29 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View magyar (HU) (94.15 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View Malti (MT) (95.95 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View Nederlands (NL) (82.05 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View norsk (NO) (82 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View polski (PL) (95.62 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View português (PT) (83.01 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View română (RO) (94.17 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View slovenčina (SK) (94.08 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View slovenščina (SL) (82.27 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View Suomi (FI) (81.54 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View svenska (SV) (82.05 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View Product information Nobivac Myxo-RHD Plus : EPAR - Product Information English (EN) (81.49 KB - PDF)First published: 16/12/2019 Last updated: 02/09/2025 View Other languages (25) български (BG) (91.78 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View español (ES) (81.51 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View čeština (CS) (92.48 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View dansk (DA) (82.05 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View Deutsch (DE) (81.72 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View eesti keel (ET) (81.22 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View ελληνικά (EL) (91.79 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View français (FR) (81.63 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View hrvatski (HR) (91.56 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View íslenska (IS) (81.52 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View Gaeilge (GA) (81.36 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View italiano (IT) (81.76 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View latviešu valoda (LV) (92.14 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View lietuvių kalba (LT) (92.19 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View magyar (HU) (92.76 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View Malti (MT) (93.86 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View Nederlands (NL) (81.15 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View norsk (NO) (81.52 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View polski (PL) (93.22 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View português (PT) (82.53 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View română (RO) (91.73 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View slovenčina (SK) (81.75 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View slovenščina (SL) (81.76 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View Suomi (FI) (81.11 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View svenska (SV) (81.47 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View Nobivac Myxo-RHD Plus : EPAR - All Authorised presentations English (EN) (81.94 KB - PDF)First published: 16/12/2019 Last updated: 02/09/2025 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View español (ES) (81.97 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View čeština (CS) (93.99 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View dansk (DA) (83.34 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View Deutsch (DE) (82.76 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View eesti keel (ET) (82.18 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View ελληνικά (EL) (93.76 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View français (FR) (82.44 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View hrvatski (HR) (92.27 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View íslenska (IS) (83.29 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View Gaeilge (GA) (83.57 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View italiano (IT) (82.29 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View latviešu valoda (LV) (94.29 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View magyar (HU) (94.15 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View Malti (MT) (95.95 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View Nederlands (NL) (82.05 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View norsk (NO) (82 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View polski (PL) (95.62 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View português (PT) (83.01 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View română (RO) (94.17 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View slovenčina (SK) (94.08 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View slovenščina (SL) (82.27 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View Suomi (FI) (81.54 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View svenska (SV) (82.05 KB - PDF) First published: 16/12/2019 Last updated: 02/09/2025 View Product details Name of medicine Nobivac Myxo-RHD Plus Active substance Live myxoma vectored RHD virus strain 009Live myxoma vectored RHD virus strain MK1899 International non-proprietary name (INN) or common name myxomatosis and rabbit haemorrhagic viral disease vaccine (live recombinant) Pharmacotherapeutic groupImmunologicals for leporidae Authorisation details EMA product number EMEA/V/C/004989 Assessment history Initial marketing authorisation documents Nobivac Myxo-RHD Plus : EPAR - Public assessment reportAdopted Reference Number: EMA/507457/2019 English (EN) (81.49 KB - PDF)First published: 16/12/2019 Last updated: 02/09/2025 View CHMP summary of positive opinion for Nobivac Myxo-RHD PlusAdopted Reference Number: EMA/CVMP/473135/2019 English (EN) (130.79 KB - PDF)First published: 13/09/2019 View News on Nobivac Myxo-RHD Plus Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 5-7 December 202308/12/2023 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 17-18 January 202320/01/2023 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 February 202221/02/2022 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 6-7 October 202009/10/2020 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 10-12 September 201913/09/2019 This page was last updated on 02/09/2025 Share this page